e-learning
resources
Vienna 2003
Sunday 28.09.2003
Epidemiology, therapy and outcome of infections in the ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Routine tracheal aspirates and adequacy of initial antibiotherapy of ventilator-associated pneumonia
L. Papazian, F. Michel, S. Donati, J. M. Sainty, M. Gainnier (Marseille, France)
Source:
Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Session:
Epidemiology, therapy and outcome of infections in the ICU
Session type:
Oral Presentation
Number:
227
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Papazian, F. Michel, S. Donati, J. M. Sainty, M. Gainnier (Marseille, France). Routine tracheal aspirates and adequacy of initial antibiotherapy of ventilator-associated pneumonia. Eur Respir J 2003; 22: Suppl. 45, 227
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diagnostic value of daily endotracheal aspirate cultures for the therapeutic management of ventilator-associated pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 477s
Year: 2002
Microbial investigation in ventilator-associated pneumonia
Source: Eur Respir J 2001; 17: 791-801
Year: 2001
Rapid quantification of bacteria associated to ventilator associated pneumonia in endotracheal aspirate specimens
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003
Follow-up cultures in ventilator-associated pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Bacteriologic quantitative culture of bronchoalveolar lavage specimens in the diagnosis of ventilator-associated pneumonia in children
Source: Eur Respir J 2003; 22: Suppl. 45, 320s
Year: 2003
Tracheotomy and ventilator-associated pneumonia: the importance of oral care
Source: Eur Respir J 2008; 31: 221
Year: 2008
Intermittent suction of oral secretion can reduce ventilator-associated pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 182s
Year: 2006
The role of the fiberoptic bronchoscopy in the management of community-acquired pneumonia in adults
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
The association of ventilator-associated pneumonia with the frequent exchange of endotracheal tube
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia
Source: Eur Respir J 2002; 19: 944-951
Year: 2002
Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012
Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients
Source: Eur Respir J 2016; 47: 1060-1061
Year: 2016
Efficacy of a ventilator bundle for the prevention of the ventilator-associated pneumonia
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011
Diagnosis of ventilator-associated pneumonia
Source: Annual Congress 2007 - Pulmonary infections and inflammation
Year: 2007
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
BAL and microbiological surveillance of nosocomial pneumonia in ARDS patients
Source: Eur Respir J 2006; 28: Suppl. 50, 786s
Year: 2006
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007
Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Source: Eur Respir J 2007; 30: 314-320
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept